The largest database of trusted experimental protocols

7 protocols using l histidine monohydrochloride

1

Trastuzumab Lyophilization Formulation Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mAb (Trastuzumab, Anti HER2 Antibody) was provided by WuXi Biologics. L-histidine monohydrochloride was obtained from Merck. L-histidine and sucrose were gained from Pfanstiehl. Polysorbate 80 (PS80) were purchased from Croda. Type 1 medium borosilicate glass tubing vials (Schott, 2 mL vial, 8 mL vial, 10 mL vial, 20 mL vial, 50 mL vial), stoppers (West, 13 mm, 20 mm) and aluminum covers (West, 13 mm, 20 mm) were used for lyophilization. Syringe of 5 mL and 10 mL were manufactured from Changzhoujinlong Co., Ltd, China.
+ Open protocol
+ Expand
2

Synthetic Media for Toxic Biogenic Amine Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Table 1 shows the composition of the two synthetic media formulated to determine the ability to form the most toxic BA (HI and TY) and their enhancers (PU and CA): Low Nitrogen Broth (LND), prepared with the objective to decrease the incidence of false positive results of bacteria with a strong peptidase (or deaminase) activity; and the Low Glucose Broth (LGD) developed with the aim to decrease the incidence of false negative responses of bacteria with a great fermentative activity. Before performing the tests both base broth media were supplemented with the precursor amino acids (l-Lysine monohydrate (Merck, Darmstadt, Germany), l-Ornithine monohydrate (Sigma-Aldrich, Steinheim, Germany), l-Histidine monohydrochloride (Merck) and l-Tyrosine disodium salt (Sigma-Aldrich), individually, or adding a mixture of all them (described in the next section as total amino acid broth). The base broth without amino acids added was used as negative control. All media were adjusted to the pH values indicated in Table 1 and autoclaved at 120 °C during 5 min.
+ Open protocol
+ Expand
3

Qualitative Detection of Biogenic Amine-Producing Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect bacteria producing biogenic amines, a qualitative test was used [43 (link)]. First, strains were inoculated at 1% (v/v) in modified MRS broth containing 0.1% (w/v) of each amino acid precursor (L-lysine, tyrosine disodium salt, L-histidine monohydrochloride and L-ornithine monohydrochloride (Sigma Aldrich, Darmstadt, Germany)) and incubated at 37 °C for 18 h. The screening was carried out using a specially formulated agar medium (0.5% tryptone, 0.5% yeast extract, 0.5% meat extract, 0.25% NaCl, 0.05% glucose, 0.1% Tween 80, 0.02% MgSO4, 0.005% MnSO4, 0.004% FeSO4, 0.2% ammonium citrate, 0.001% thiamine, 0.2% K2PO4, 0.01% CaCO3, 0.005% pyridoxal-5-phosphate, 1% amino acid precursor, 0.006% bromocresol purple, 2% agar; pH 5.3). For this, 10 µL of each culture was spotted on the medium containing the same amino acids precursor. After 4 days of incubation at 37 °C, a positive result was indicated by the color change and by amino acid precipitation around the corresponding spot for tyramine only. The assays were conducted in duplicate.
+ Open protocol
+ Expand
4

Heterologous Protein Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tryptone enzymatic digest, yeast extract, glycerol, potassium phosphate dibasic, potassium phosphate monobasic, L-histidine monohydrochloride, ampicillin sodium salt, phenylmethylsulfonyl fluoride (PMSF), sodium chloride, ethylenediaminetetraacetic acid (EDTA), chloramphenicol, Terrific Broth, deoxyribonuclease I and ribonuclease A were purchased from Sigma-Aldrich (St. Louis, MO, USA). Difco Luria-Bertani broth lennox from Becton Dickinson (Franklin Lakes, NJ, USA). Isopropyl β-F-1-thiogalactopyranoside (IPTG) Dioxane-Free and 5-aminolevulinic acid hydrochloride were obtained from BOC Sciences (Upton, NY, USA). CHAPS(2-2-Cholamidopropyldimethylammonio)-1-propanesulfonate and Tris(2-carboxyethyl)phosphine hydrochlorate (TCEP) were obtained from Soltec venture (Beverly, MA, USA). HisPur Ni-NTA resin was from ThermoFisher Scientific (Waltham, MA, USA). CM Macroprep was from Bio-Rad (Hercules, CA, USA). 5-Cyclohexyl-1-hexylpentyl-β-D-maltoside (CYMAL-5) was obtained from Anatrace (Maumee, OH, USA). The 3α-Hydroxyl-7α,12α-di-(((2-(trimethylamino)ethyl)phosphoryl)ethyloxy)-cholane (FA-7/234-chol) is a facial amphiphile used as described previously [31 (link)]. PEGRx screens were obtained from Hampton Research. Human cytochrome P450 reductase was obtained from OriGene (Rockville, MD, USA).
+ Open protocol
+ Expand
5

Biogenic Amine Production Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of the CNS strains to produce biogenic amines (histamine, cadaverine, tyramine and putrescine) was phenotypically evaluated following the protocol described by Bover-Cid and Holzapfel [14 (link)]. The strains were grown on a plate with Bover-Cid medium containing the corresponding precursor amino acid at 1% final concentration (L-histidine monohydrochloride, tyrosine disodium salt, L-ornithine monohydrochloride and lysine monohydrochloride), (Sigma-Aldrich, Steinheim, Germany). Strains were streaked in duplicate on the decarboxylase medium plates with and without amino acids (as control) and were incubated for 4 days at 37 °C, under aerobic conditions. The pH variation due to the BA production changes the medium color from yellow-green to light or dark purple.
+ Open protocol
+ Expand
6

Synthesis and Characterization of Semiconductor Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cadmium chloride hemi(pentahydrate) (CdCl2·2.5H2O, >99%), zinc acetate dihydrate (Zn(OAc)2·2H2O, >99%), tellurium (Te, >99.8%), sodium borohydride (NaBH4, >96%), 3-mercaptopropionic acid (MPA, 99%), acrylamide (>98%), ethylene glycol dimethylacrylate (EGDMA, 98%), potassium persulfate (K2S2O8, >99%), dopamine hydrochloride (DA·HCl, 99%), adenosine 5′-diphosphate (ADP, >95%), l-arginine (Arg, >98%), l-histidine monohydrochloride monohydrate (His, >98%), l-lysine (Lys, >98%), l-serine (Ser, >99%), l-cysteine (Cys, 97%), l-tyrosine (Tyr, >98%), glycine (Gly, >98.5%), homovanillic acid (HVA, fluorimetric reagent), l-glutathione (GSH, >98%), bovine serum albumin (BSA, >96%), (d)-(+)-glucose (>99.5%), ascorbic acid (AA, >99%), l-aspartic acid (Asp, >98%), KCl (>99%), NaCl (>99%), CaCl2 (>96%), and MgCl2·6H2O (>99%) were purchased from Sigma-Aldrich (Saint-Quentin Fallavier, France) and were used without purification. All solutions were prepared with deionized water (18.2 MΩ cm). Phosphate-buffered saline (PBS) solution was prepared using [Na2HPO4·2H2O] = 0.2 M, [NaH2PO4·H2O] = 0.2 M and the final pH was adjusted to 7.4.
+ Open protocol
+ Expand
7

Histamine-Producing Bacteria Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histamine producing bacteria (HPB) detection was done by Niven's methods (Niven et al., 1981) . Histamine-producing bacteria were inoculated on agar plates containing Niven's medium (0.5% tryptone, 0.5% yeast extract, 2.0% L-histidine-monohydrochloride was purchased from Sigma (Sigma Aldrich), 0.5% NaCl, 0.1% CaCO3, 2.0% agar and 0.006% bromo cresol purple, at pH 5.3) which was sterilized at 121°C for 10 min. The plates were incubated at 37°C for 48 hrs. aerobically (Lopes -Sabater et al., 1996) . Purple zone appeared around colony is an indicator of histamine producing bacteria. When the indicator showed an increase of pH on agar plates containing Niven's medium. To determine histamine qualitative assay of isolates, the purple zone diameter (mm) was measured. The colonies of these zones were transferred to new plates, and the morphology of the colonies was observed under a microscope following Gram staining.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!